Skip to Content
Merck
  • Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.

Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.

Antimicrobial agents and chemotherapy (1992-11-01)
M Picard, F Malouin
ABSTRACT

Cefaclor sustained its inhibitory activity against a beta-lactamase-producing strain of Haemophilus influenzae. Although a relatively high permeability coefficient was calculated for ampicillin compared with that calculated for cefaclor, the resulting periplasmic concentration of cefaclor was 5.7 times that of ampicillin. The efficacy of cefaclor may be due to its higher beta-lactamase resistance, which allows it to achieve a greater periplasmic concentration and adequate binding to crucial penicillin-binding proteins.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cefaclor